Unnatural Products, Novartis sign license deal worth up to $1.7 billion for cardiovascular program

Unnatural Products, Novartis sign license deal worth up to $1.7 billion for cardiovascular program | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]A sign marks the Novartis Institutes for BioMedical Research facility in Cambridge, Massachusetts, U.S., June 16, 2021. REUTERS/Brian Snyder [Purchase Licensing Rights, opens new tab]- Companies[Novartis]FollowFeb 18 (Reuters) - Unnatural Products said on Wednesday it has signed a licens ...